Adding to a flurry of activity around cell and regenerative therapies in Japan over the past few months, local venture Healios KK has begun recruiting for a clinical trial with a novel cell therapy for acute respiratory distress syndrome (ARDS).
The development suggests that the environment for such products in the country continues to be positive, despite some rumblings that...







